Skeletal muscle regeneration using mesenchymal system cells

US9757419B2 · kind B2 · utility

Assignee

• PLURISTEM LTD. · IL

Inventors

• Georg Duda · Berlin, DE
• Tobias Winkler · Hamburg, DE
• Georg Matziolis · Jena, DE
• Philipp Von Roth · Berlin, DE
• Carsten Perka · Berlin, DE

Key dates

• Filing date: May 27, 2011
• Grant date: Sep 12, 2017
• Expiry date: May 27, 2031

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K2035/124
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to a therapeutic substance and/or medicament and methods relating to the use of said substance and/or medicament for skeletal muscle regeneration using mesenchymal stem cells (MSCs) which can be applied directly or shortly after muscle damage or injury.